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Abstract 
Background: Obtaining population-level estimates of the incidence and prevalence of dementia is challenging due 
to under-diagnosis and under-reporting. We investigated the feasibility of using multiple linked datasets and capture–
recapture techniques to estimate rates of dementia among women in Australia.
Methods: This work is based on the Australian Longitudinal Study on Women’s Health. A random sample of 12,432 
women born in 1921–1926 was recruited in 1996. Over 16 years of follow-up records of dementia were obtained from 
five sources: three-yearly self-reported surveys; clinical assessments for aged care assistance; death certificates; phar-
maceutical prescriptions filled; and, in three Australian States only, hospital in-patient records.
Results: A total of 2534 women had a record of dementia in at least one of the data sources. The aged care assess-
ments included dementia records for 79.3% of these women, while pharmaceutical data included 34.6%, death cer-
tificates 31.0% and survey data 18.5%. In the States where hospital data were available this source included dementia 
records for 55.8% of the women. Using capture–recapture methods we estimated an additional 728 women with 
dementia had not been identified, increasing the 16 year prevalence for the cohort from 20.4 to 26.0% (95% confi-
dence interval [CI] 25.2, 26.8%).
Conclusions: This study demonstrates that using routinely collected health data with record linkage and capture–
recapture can produce plausible estimates for dementia prevalence and incidence at a population level.
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Background
In Australia, it is estimated that 9% of people aged over 
65, and 30% of those aged over 85 have dementia [1]. 
However, many of the estimates of dementia prevalence 
have been based on older datasets drawn from other 
countries [2], or from a single small area data set [1].
Despite expected increases in the number of people 
with dementia due to population ageing, there is some 
evidence that the age-specific incidence rates of demen-
tia in first world countries may be declining as more 
recent generations are reaching old age [3–5], possibly 
because of increased education [6–8], more stimulating 
environments [9], and advances in the control of vas-
cular risk factors [4, 10]. Due to these competing age 
and cohort effects, a more complete understanding of 
how the case load of dementia is changing over time is 
required, for example, for public policy. Methods to 
obtain accurate and current estimates of rates of demen-
tia are necessary to assess the health service needs of the 
elderly at a population level.
The Australian Longitudinal Study on Women’s Health 
(ALSWH) is a prospective national survey [11]. Three-
yearly surveys and linked administrative records present 
an opportunity to estimate the overall incidence and 
prevalence of dementia using capture–recapture meth-
ods [12]. This approach has rarely been used before for 
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An assessment of the value of these methods is impor-
tant, as there are no standard population based surveil-
lance systems for dementia using routinely collected 
data, and under-diagnosis and under-reporting of people 
living with dementia are well established [15].
The aim of this study is to demonstrate the use of this 
approach to obtain an accurate and up to date estimate of 
dementia rates in Australian women.
Methods
Data from 12,432 women born between 1921 and 1926 
(estimated response rate 37–40%), who responded to the 
ALSWH baseline survey in 1996, were used as a starting 
point to assess rates of dementia [16, 17].
The ALSWH is a nationally representative study which 
includes women from every Australian State and Ter-
ritory [11]. The study sample was selected by Medicare 
Australia, the universal health care insurance scheme. 
Sampling was random, with women from rural and 
remote areas sampled at twice the rate of women in 
urban areas to facilitate comparisons between these 
groups [17]. The ALSWH sample of older women was 
generally representative of Australian women of the same 
age, but did include more women who were married or 
living with their partner, and more women with post-
school qualifications, compared to the 1996 Australian 
Census [11, 16]. Each participant has a unique Medicare 
identification number which is used in some, but not all, 
administrative data sources thereby enabling determinis-
tic record linkage.
Data sources
Five data sources were used to identify records of demen-
tia and Alzheimer’s disease in these women between 31 
May 1996 and 6 March 2012 (the dates of first and last 
full surveys received from this cohort). We will refer to 
these as ‘dementia’ records throughout the paper.
Self‑reported survey data (A)
The survey data consisted of six surveys which occurred 
at 3-year intervals. Participants (or their proxies) were 
asked in Surveys 2–6 whether they had been diagnosed 
with or treated for dementia. Surveys 4 and 5 contained 
a free-text field where participants (or proxies) could 
explain reasons why they needed help to complete the 
survey. This text was searched for the terms ‘Alzheimer’s 
and ‘dementia’. Information on self-reported medication 
collected from Survey 4, and coded using the Anatomi-
cal Therapeutic Chemical index [18], was also used to 
identify women who used anti-dementia drugs (Addi-
tional file 1: Table A1). The date of survey response was 
used as a date of notification for each identified case. 
Notifications of dementia from this source commenced 
in 1999 (Survey 2 onwards).
Aged care assessments (B)
Aged care assessment data were obtained from the Aus-
tralian Institute of Health and Welfare [1], who extracted 
records for all ALSWH participants in the 1921–1926 
cohort. As not all aged care records included the Medi-
care number, probabilistic linkage methods were used 
[19]. The matching process employed both name based 
linkage and key based linkage techniques. These link-
ages to the ALSWH data were estimated to have a sen-
sitivity over 94% and a positive predictive value above 
96% (AIHW communication). There were several sources 
used to identify dementia records: the Extended Care at 
Home Dementia Program; the Aged Care Assessment 
Program (which assesses the care needs of older people 
and assists in the access of appropriate types of care); and 
the Aged Care Funding Instrument (which assesses care 
needs as a basis for calculating and allocating funds to 
the aged care facility). As part of the Aged Care Assess-
ment Program and the Aged Care Funding Instrument, 
diagnostic codes of dementia were recorded (Additional 
file 1: Table A1). These diagnoses were obtained through 
referrals to a general practitioner, geriatrician or psy-
cho-geriatrician, or through an assessor (with consent) 
accessing medical history information from a relevant 
doctor. Each record had a date of service or assessment. 
Notifications of dementia from this source were available 
from July 2003.
Causes of death (C)
Information on date and multiple causes of death was 
obtained from the National Death Index and the National 
Mortality Database [20]. Probabilistic matching, using 
names, date of birth and gender, was used to identify 
deaths among ALSWH participants [21]. Records of 
dementia or Alzheimer’s disease were identified using 
ICD9 and ICD10 codes (Additional file 1: Table A1).
Pharmaceutical Benefits Scheme (D)
Information on drug prescriptions filled was obtained 
from Pharmaceutical Benefits Scheme records which 
cover all medications dispensed and/or subsidised under 
the universal national health insurance scheme [22]. 
Deterministic linkage of records for all ALSWH partici-
pants was conducted using their unique Medicare num-
bers [23]. This data source included prescription details, 
but not the reason for the prescription, for all subsidised 
prescriptions from July 2002 to June 2012. For women 
in this age group most prescriptions are subsidised, so 
the medication records are likely to be complete. The 
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medications were coded using the ATC index [18] (Addi-
tional file 1: Table A1).
Admitted patients hospital data (E)
Hospital admissions data were available from three Aus-
tralian States (New South Wales, Queensland and South 
Australia). These data were extracted by health data link-
age units in these jurisdictions using probabilistic match-
ing [24–26]. Date of admission and doctor assigned 
diagnoses, coded using ICD10, were recorded [27]. The 
codes which indicated dementia or Alzheimer’s disease 
are provided in Additional file  1: Table A1. This data 
source included admissions from June 2000.
Statistical analysis
The linked data were used to identify the total number 
of women with dementia records (from any of the avail-
able data sources), and to assess the overlap between these 
sources. The hospital data were not included in the primary 
analysis because these data were only available for three 
Australian States. Poisson regression was used to estimate 
the number of women with dementia who were not identi-
fied from any of the four (or five) sources [12]. The outcome 
of the model was the count of women with dementia iden-
tified from each combination of sources. The independent 
variables were indicators (1/0) for each data source, and 
possible interactions between these sources. The estimated 
number of ‘unidentified’ women with dementia was the 
exponent of the constant term in the Poisson model.
With four sources (i.e., self-reported survey, aged care 
assessments, causes of death and pharmaceuticals) there 
were 113 possible log-linear models [12]. Model averag-
ing was used to obtain a weighted estimate of the number 
of unidentified women with dementia [28, 29]. This tech-
nique weights estimates from each model based on how 
well it fits the data, and then uses these weights to create 
an average estimate [Additional file  1: Table A2 (equa-
tions A1–A5)].
An overall estimate of the number of ‘unidentified’ 
women with dementia was calculated. Separate estimates 
for each age group were also produced and a pooled 
total was obtained (Additional file 1: Table A2, equations 
A6–A8). The following age groups (based on numbers of 
records) were used: 68–78, 79–80, 81–82, 83–84, 85–86 
and 87–91, which ensured that almost all combinations 
of data sources were used for each model. If no records 
were identified from a specific combination of sources, a 
correction factor of (0.5)g−1 was added to that cell (where 
g is the number of sources) [12]. If records were identi-
fied from different sources in different age groups, the 
earliest date of a dementia record was used.
One of the assumptions of the capture–recapture 
method is that the population is closed, meaning that 
no individuals can migrate into or out of the study or be 
lost because of death [12]. In this analysis no new women 
entered the cohort, however, 5453 women died over the 
duration of follow-up and emigrations were possible, 
though unlikely. An adjustment was made to each esti-
mate of the number of ‘unidentified’ women with demen-
tia to account for those who died. This adjustment was 
based on the median date of death in each age group 
(Additional file 1: Table A2, equation A6). A 95% confi-
dence interval [CI] for the estimated number of women 
with dementia from the capture–recapture analysis was 
produced. This confidence interval adjusts for sampling 
variation, and does not represent uncertainty regarding 
model assumptions [12].
The effect of including the hospital data as a fifth source 
was assessed in an analysis limited to the three States for 
which hospital data were available. In this analysis, four 
source and five source capture–recapture models were 
fitted and the results compared. Using five sources 6893 
possible log-linear models were considered.
Prevalence and incidence rates were calculated by sin-
gle year of age and then collapsed into 5-year age groups. 
For women identified with dementia from any of the 
sources, the earliest date of notification, date of birth and 
date of death were used in the calculation of prevalence 
and incidence rates. Deaths that occurred in any year 
might reduce the number women living with dementia 
in the numerator of the rate and would reduce the total 
number at risk in the denominator in both the prevalence 
and incidence calculations. For the ‘unidentified’ women 
living with dementia we knew the age group in which the 
diagnosis was estimated to have occurred, however, we 
did not have a date of death. To include these ‘unidenti-
fied’ women living with dementia in the prevalence and 
incidence calculations, for each age group (68–78, 79–80, 
etc.) a diagnosis of dementia was randomly assigned to 
the same number of women who were still alive at that 
age and did not have a record of dementia from any 
source. Additional records based on the percentage 
increase in age specific estimates, due to the inclusion 
of the hospital data in the five-source analysis, were also 
assigned in this way. This process was repeated 10 times 
to examine how the random allocation of the ‘unidenti-
fied’ women with dementia changed the results.
In all the analyses we assumed that all records of 
dementia reflect a participant’s true dementia status, and 
that a proportion of those without a record of dementia 
may also have dementia (i.e., the ‘unidentified’ cases).
Results
A total of 2534 out of 12,432 (20.4%) women were identi-
fied as having dementia in at least one of the four main 
data sources (Table  1). The largest number of dementia 
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records was identified from the aged-care assessments 
(2010 women, 16.2% of all the women and 79.3% of those 
with dementia records). Of the women with a record of 
dementia from the aged-care assessments, 65% had the 
dementia recorded more than once within this source. 
The source yielding the smallest number of demen-
tia records was the self-reported survey data (18.5% of 
records). Of these self-reported records, 17.3% were 
reported with the help of a proxy, while the death cer-
tificates and pharmaceutical data had 31.0 and 34.6% of 
records respectively. In the States where hospital data 
were available, 55.8% of women with dementia were 
identified in this data source. There were 50 women (0.4% 
of all the women) with records in all four of the nationally 
available datasets, and 1329 (10.6% of all women) from 
one source only (Table 2).
Using capture–recapture methods we estimated that 
there were 695 ‘unidentified’ women with dementia. 
Therefore the estimated total number of women with 
dementia was 3229, 95% CI (2976, 3482) or 26.0%, 
95% CI (25.2, 26.8%) (cumulative incidence above the 
age of 70) (Table 2). The difference between the num-
ber of identified women with dementia (2534) and 
the capture–recapture estimate (3229) suggests that 
only using the available datasets would have under-
estimated the number of women with dementia by 
27% (695/2534). The correction used on cells with no 
records had only a marginal effect on the estimates 
presented, as did the adjustment for deaths in each age 
category (Table 2). The effect of including the hospital 
data was assessed by restricting the analyses to women 
in New South Wales, Queensland and South Australia. 
The inclusion of the hospital data increased the esti-
mated total percentage of women who had dementia 
slightly to 26.9%, 95% CI (26.0, 27.9%) (Additional 
file 1: Tables A3 and A4).
The average length of time to death or the end of fol-
low-up was 13.0 years [standard deviation (SD) 4.1], and 
the average time to dementia, death or end of follow-up 
period was 11.3 years (SD 3.2). The prevalence and inci-
dence of dementia are underestimated for the ages 70–79 
because only self-reported survey data and cause of death 
data were available for the period 1996–2000. Using the 
capture–recapture estimates, rates of prevalence and 
incidence of dementia for ages 85+ are approximately 
double than in the ages 80–84 estimates (Table  3). The 
prevalence and incidence estimates changed only slightly 
when the ten different random allocations of ‘unidenti-
fied’ dementia records in each age group were used (data 
available on request).
Dementia prevalence and incidence rates from the 
ALSWH study, compared to estimates from other inter-
national studies for women aged 80–85 and 85–89, are 
presented in Table 4. The prevalence and incidence rates 
of dementia for women aged 80–84 and 85+, based on 
identified records were broadly consistent with those 
reported previously. In contrast, estimates based on 
the capture–recapture techniques were higher than 
previously published prevalence and incidence figures 
(Table 4).





E = Hospital admission patients data (only for Queensland, New South Wales, and South Australia; Total n = 7750)
a Age dementia was first recorded
b Row percentages do not add up to 100% because cases can be identified from more than one source
Self‑reported survey Aged care data Causes of death Pharmaceutical/prescription Hospital data
Total identified cases A B C D E
N = 2534 N = 468 N = 2010 N = 786 N = 877 N = 983
% of identified casesb 18.5% 79.3% 31.0% 34.6% 55.8%
Median age in years (quartiles)a 83.2 (79.9, 86.2) 85.1 (83.1, 86.8) 85.0 (82.8, 86.8) 82.7 (80.4, 85.2) 84.3 (81.8, 86.6)
Age (years)a n (%) n (%) n (%) n (%) n (%)
<75 18 (3.8) 0 7 (0.9) 0 1 (0.1)
75–79 108 (23.1) 85 (4.2) 55 (7.0) 172 (19.6) 155 (15.8)
80–84 174 (37.2) 889 (44.2) 326 (41.5) 440 (50.2) 404 (41.1)
85–89 164 (35.0) 1009 (50.2) 379 (48.2) 259 (29.5) 403 (41.0)
≥90 4 (0.9) 26 (1.3) 11 (1.4) 6 (0.7) 20 (2.0)
Unknown 1 (0.05) 8 (1.0)
Page 5 of 9Waller et al. Emerg Themes Epidemiol  (2017) 14:3 
Discussion
By March 2012, 16% of ALSWH participants who were 
aged between 71 and 75 in 1996, were recorded as hav-
ing dementia from the largest single data-source (aged 
care assessments), and 20% of women were identified 
from one of the four primary data sources. Using cap-
ture–recapture methods the estimated percentage of 
women who had dementia increased from 20 to 26%. 
These results highlight the importance of using multi-
ple sources of data, estimating the number people with 
dementia who may have been missed, and including this 
‘undercount’ in the presentation of results. This differ-
ence in the estimated prevalence of dementia would have 
significant implications for the planning and provision of 
health service needs in older women.
Whilst the methods of identifying records of demen-
tia vary between data sources, the dementia records 
from the aged care assessment data, cause of death data, 
and admitted patients hospital data, were all based on 
doctors’ diagnoses. Dementias recorded with the help 
of proxies were included in the self-reported dataset, 
which allowed us to include women who may not have 
been able to complete the survey alone. However, less 
than 4% of identified dementia cases were based on 
self-reported ALSWH records alone. The use of five 
different sources of dementia notifications strengthens 
confidence in the analysis and the estimates obtained. 
The model averaging technique is another strength of 
the analysis. Using this technique, the results do not 
dependent on only one model, but are drawn from a 
Table 2 Number of  new records of  dementia by  age, as  identified by  different combinations of  four data sources 
(n = 12,432)






68–78 79–80 81–82 83–84 85–86 87–91 Total
A 27 17 12 10 13 20 99
B 9 37 81 204 283 289 903
C 29 35 45 41 37 24 211
D 8 11 22 27 24 24 116
AB 11 14 17 25 37 17 121
AC 22 11 2 3 2 1 41
AD 4 2 1 2 4 5 18
BC 6 33 48 77 57 33 254
BD 24 54 76 98 84 51 387
CD 12 10 6 3 1 0 32
ABC 7 5 5 6 2 3 28
ABD 10 29 20 20 16 9 104
ACD 2 2 2 0 1 0 7
BCD 19 44 54 28 18 0 163
ABCD 16 16 12 3 3 0 50
Identified 
number
206 320 403 547 582 476 2534
Estimated extra 30 41 116 128 164 217 728
Total =  
identified +  
extra
236 361 519 675 746 693 3262
95% CI 201, 272 342, 380 411, 627 553, 797 634, 857 537, 848 2823, 4370
Adjustment for 
deaths
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number of the best fitting models. This is important, 
because for the capture–recapture analysis of four and 
five data sources there were 114 and 6893 possible mod-
els, respectively.
Previous research from the ALSWH showed that the 
probabilistic matching with the National Death Index 
correctly identified 95% of deaths [21], likewise the age-
care data linkage reported high sensitivity and positive 
predictive values estimates of the sensitivity and PPV 
above 94% (AIHW communication). This gives confi-
dence in the accuracy of the probabilistic linkage tech-
niques. Aged care assessments identified the largest 
number of dementia records. Within the age care data, 
more than one record of dementia was present for 65% of 
dementia cases identified from this source.
Nevertheless it is possible that the number of demen-
tia records identified from some sources have been over-
estimated. For example, in hospital records temporary 
conditions which had similar symptoms could have been 
misclassified as dementia (e.g., delirium, or other condi-
tions which cause behavioural changes). However, the hos-
pital records were based on doctors’ diagnoses, and 82% 
of the dementia records identified from the hospital data 
were also identified from at least one other data source.
Although the ALSWH participants were generally rep-
resentative of the population of Australian women [11, 
16], previous analysis of the 1921–1926 cohort indicated 
that these women had slightly lower death rates than 
observed in the general population [30]. If the ALSWH 
participants were healthier than the general popula-
tion then the population-wide prevalence of dementia 
may be underestimated, if ‘healthier’ women were less 
susceptible to dementia. On the other hand, the preva-
lence at older ages may be overestimated if the partici-
pants’ longer life expectancy increased the age-related 
risk of dementia.
One of the assumptions of capture–recapture methods is 
that the population analysed is ‘closed’, with no one entering 
or leaving. Although in our analysis no additional women 
entered the study cohort, 44% of the cohort died during the 
follow-up period. Women leaving the cohort (primarily due 
to death) may have caused us to underestimate the number 
of women with dementia. We adjusted for deaths in each 
age group to reduce the probability of assigning dementia 
to deceased study participants. This adjustment had only a 
small effect on the estimates presented.
The use of a defined cohort of women in the analysis 
meant that the calculation of rates of dementia was straight-
forward. However, four of the five data sources used were 
routinely collected administrative records (all except self-
reported survey data). As such these sources could poten-
tially be used to estimate rates of dementia at the population 
level, through data-linkage techniques. This approach would 
have the advantage of using rates based on the ‘whole popu-
lation’. However, the assumptions for the capture–recapture 
methods may be more tenuous if there are difficulties defin-
ing the denominator and estimating the number of people 
entering and leaving the population studied [12].
The rates of incidence and prevalence of dementia for 
ages below 80 in this analysis were underestimated. Three 
of the datasets only had records available after the year 
2000, so would not have contributed cases identified ear-
lier in the study. For this reason the estimates of demen-
tia prevalence and incidence rates in women aged less 
Table 3 Prevalence and incidence of dementia by age
a Estimated cases = identified cases + estimated extra cases (based on inclusion of hospital data)
b Prevalence and incidence for ages 70–74 and 75–79 are underestimated because only self-reported data and cause of death data were available for the period 
1996–2000
Age Prevalence: identified dementia cases Prevalence: estimated dementia casesa
Identified dementia cases N Prevalence % 95% CI Estimated dementia casesa N Prevalence % 95% CI
70–74b 25 11,846 0.2 (0.1, 0.3) 37 11,846 0.3 (0.2, 0.4)
75–79b 352 12,029 2.9 (2.6, 3.2) 450 12,029 3.7 (3.4, 4.1)
80–84 1385 10,803 12.8 (12.1, 13.5) 1794 10,803 16.6 (15.9, 17.3)
85+ 1946 8817 22.1 (21.2, 22.9) 2735 8817 31.0 (30.0, 32.0)
Incidence: identified dementia cases Incidence: estimated dementia casesa
Identified 
dementia cases
Person‑years Incidence rate 
per 100  
person‑years
95% CI Estimated 
dementia casesa




70–74b 25 29,225.81 0.09 (0.06, 0.13) 37 29,210.15 0.13 (0.09, 0.17)
75–79b 335 56,712.76 0.59 (0.53, 0.66) 423 56,560.95 0.75 (0.68, 0.82)
80–84 1116 46,569.31 2.40 (2.33, 2.54) 1456 45,676.17 3.19 (3.02, 3.34)
85+ 1058 22,076.41 4.78 (4.51, 5.09) 1532 20,596.46 7.44 (7.07, 7.82)
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than 80 are lower than those reported in other Australian 
and international studies [3–5, 31–37].
The prevalence and incidence rates of dementia for 
women aged 80–84 and 85+, based on identified records 
were broadly consistent with those reported previously, 
indicating that the estimates gained through linkage of 
multiple sources are credible (see Table 4) [5, 31–37]. Over 
the age of 80 estimates based on the capture–recapture 
techniques were somewhat higher than those estimates 
published. It is therefore possible that the previously pub-
lished estimates which did not account for the number of 
‘unidentified’ women with dementia are underestimates.
There is evidence from other countries that some types 
of routinely collected data, such as United States Medi-
care claims (which do not have universal coverage, and 
cover a different range of services from the Australian 
Medicare), may overestimate the prevalence of demen-
tia [38], so the use of some of the multiple linked data 
sources may have inflated these estimates, compared to 
other studies which used clinical assessments on all study 
participants [39, 40]. However, a recent UK study found 
dementia recorded in hospital admission data, agreed 
well with primary care records of dementia [41].
Other studies of dementia have used measures such as 
Mini-Mental State Examination, the Geriatric Mental 
State—Automated Geriatric Examination for Computer 
Assisted Taxonomy diagnosis algorithm, or an interview 
or clinical assessment to define dementia [3, 34, 36, 39, 
40]. The current study uses more diverse assessments of 
dementia collected from 5 separate data sources. However, 
the rates we present give estimates of older women identi-
fied as having dementia in different health care settings.
The use of existing linked data to identify people liv-
ing with dementia, as demonstrated in this study, has 
clear advantages in large population based studies over 
separate study-specific individual clinical assessments to 
determine diagnoses. For the purposes of public policy 
and planning of health services these methods can pro-
vide population-level estimates as well as sub-population 
comparisons (e.g., between urban and rural areas and for 
socially disadvantaged groups) and trends over time.
Conclusions
This study demonstrates using routinely collected health 
data with record linkage and capture–recapture methods 
can produce plausible estimates for dementia prevalence 
and incidence.
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